These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23211512)

  • 1. Neuropeptide Y and somatostatin inhibit insulin secretion through different mechanisms.
    Schwetz TA; Ustione A; Piston DW
    Am J Physiol Endocrinol Metab; 2013 Jan; 304(2):E211-21. PubMed ID: 23211512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential stimulation of insulin secretion by GLP-1 and Kisspeptin-10.
    Schwetz TA; Reissaus CA; Piston DW
    PLoS One; 2014; 9(11):e113020. PubMed ID: 25401335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phentolamine reverses NPY-induced inhibition of insulin secretion in isolated rat islets.
    Alwmark A; Ahrén B
    Eur J Pharmacol; 1987 Mar; 135(3):307-11. PubMed ID: 2884123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of neuropeptide Y and pancreatic polypeptide on islet function and beta-cell survival.
    Khan D; Vasu S; Moffett RC; Irwin N; Flatt PR
    Biochim Biophys Acta Gen Subj; 2017 Apr; 1861(4):749-758. PubMed ID: 28069397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin secretion is increased in pancreatic islets of neuropeptide Y-deficient mice.
    Imai Y; Patel HR; Hawkins EJ; Doliba NM; Matschinsky FM; Ahima RS
    Endocrinology; 2007 Dec; 148(12):5716-23. PubMed ID: 17717054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SSTR2 is the functionally dominant somatostatin receptor in human pancreatic β- and α-cells.
    Kailey B; van de Bunt M; Cheley S; Johnson PR; MacDonald PE; Gloyn AL; Rorsman P; Braun M
    Am J Physiol Endocrinol Metab; 2012 Nov; 303(9):E1107-16. PubMed ID: 22932785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice.
    Strowski MZ; Parmar RM; Blake AD; Schaeffer JM
    Endocrinology; 2000 Jan; 141(1):111-7. PubMed ID: 10614629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of glucose stimulated insulin secretion by neuropeptide Y is mediated via the Y1 receptor and inhibition of adenylyl cyclase in RIN 5AH rat insulinoma cells.
    Morgan DG; Kulkarni RN; Hurley JD; Wang ZL; Wang RM; Ghatei MA; Karlsen AE; Bloom SR; Smith DM
    Diabetologia; 1998 Dec; 41(12):1482-91. PubMed ID: 9867216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin secretion in rats: effects of neuropeptide Y and noradrenaline.
    Pettersson M; Ahrén B
    Diabetes Res; 1990 Jan; 13(1):35-42. PubMed ID: 2097094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of D-myo-inositol-1,2,6-trisphosphate on glucose-stimulated insulin secretion in the mouse.
    Ahrén B
    Neuropeptides; 1992 Mar; 21(3):163-6. PubMed ID: 1630602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y promotes beta-cell replication via extracellular signal-regulated kinase activation.
    Cho YR; Kim CW
    Biochem Biophys Res Commun; 2004 Feb; 314(3):773-80. PubMed ID: 14741702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Role for Somatostatin in the Survival of Mouse Pancreatic Beta Cells.
    Damsteegt EL; Hassan Z; Hewawasam NV; Sarnsamak K; Jones PM; Hauge-Evans AC
    Cell Physiol Biochem; 2019; 52(3):486-502. PubMed ID: 30873823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin and somatostatin modulate the glucose-induced insulin secretion by different mechanisms in pancreatic islets. A study on phospholipase C activity and calcium requirement.
    Malm D; Giaever A; Vonen B; Florholmen J
    Scand J Clin Lab Invest; 1993 Nov; 53(7):671-6. PubMed ID: 7903820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired insulin secretion by diphenyleneiodium associated with perturbation of cytosolic Ca2+ dynamics in pancreatic beta-cells.
    Imoto H; Sasaki N; Iwase M; Nakamura U; Oku M; Sonoki K; Uchizono Y; Iida M
    Endocrinology; 2008 Nov; 149(11):5391-400. PubMed ID: 18617620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The somatostatin receptor in human pancreatic β-cells.
    Braun M
    Vitam Horm; 2014; 95():165-93. PubMed ID: 24559918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic amplification of insulin secretion by glucose is independent of β-cell microtubules.
    Mourad NI; Nenquin M; Henquin JC
    Am J Physiol Cell Physiol; 2011 Mar; 300(3):C697-706. PubMed ID: 21178111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin receptor subtype 5 regulates insulin secretion and glucose homeostasis.
    Strowski MZ; Kohler M; Chen HY; Trumbauer ME; Li Z; Szalkowski D; Gopal-Truter S; Fisher JK; Schaeffer JM; Blake AD; Zhang BB; Wilkinson HA
    Mol Endocrinol; 2003 Jan; 17(1):93-106. PubMed ID: 12511609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of effects of neuropeptide Y and norepinephrine on insulin secretion and vascular resistance in perfused rat pancreas.
    Skoglund G; Gross RA; Bertrand GR; Ahrén B; Loubatières-Mariani MM
    Diabetes; 1991 Jun; 40(6):660-5. PubMed ID: 2040381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taurine supplementation ameliorates glucose homeostasis, prevents insulin and glucagon hypersecretion, and controls β, α, and δ-cell masses in genetic obese mice.
    Santos-Silva JC; Ribeiro RA; Vettorazzi JF; Irles E; Rickli S; Borck PC; Porciuncula PM; Quesada I; Nadal A; Boschero AC; Carneiro EM
    Amino Acids; 2015 Aug; 47(8):1533-48. PubMed ID: 25940922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for islet somatostatin in mediating sympathetic regulation of glucagon secretion.
    Hauge-Evans AC; King AJ; Fairhall K; Persaud SJ; Jones PM
    Islets; 2010; 2(6):341-4. PubMed ID: 21099335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.